Sonova (OTCMKTS:SONVY) Shares Pass Above Fifty Day Moving Average – Time to Sell?

Sonova Holding (OTCMKTS:SONVY)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $46.75 and traded as high as $47.08. Sonova shares last traded at $46.09, with a volume of 52,866 shares traded.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Jefferies Financial Group downgraded Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Zacks Research upgraded Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Finally, BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Sonova Price Performance

The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. The stock has a 50 day simple moving average of $46.75 and a 200 day simple moving average of $50.55.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.